1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical information for patients with SAH with multiple IAs
Clinical Information Demographics and comorbidities (n = 93) Age (mean) (yr) 60 ± 13 Female sex 69 (74%) Hypertension 59 (63%) Smoking history 35 (38%) Coronary artery disease 7 (8%) Hyperlipidemia 28 (30%) Diabetes mellitus 13 (14%) Polycystic kidney disease 1 (1%) Received treatment Clipping 35 (38%) Endovascular 53 (57%) No treatment 5 (5%) Aneurysm multiplicity 2 Aneurysms 76 (82%) 3 Aneurysms 15 (16%) 4 Aneurysms 1 (1%) 5 Aneurysms 1 (1%)